Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 625 of 3499 entries
View as:

Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement

Phase: N/A Priority: Normal
NCT ID: NCT03724084 Org: User:
Start: 04/10/19 End: 11/14/22 Due: 11/14/23

Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03008278 Org: User:
Start: 02/06/18 End: 08/15/25 Due: 08/15/26

Tabectedin to Treat Children and Adolescents With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01453283 Org: User:
Start: 12/20/06 End: 10/11/11 Due: 10/11/12

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00001445 Org: User:
Start: 08/31/95 End: 07/31/01 Due: 07/31/02

Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00024089 Org: User:
Start: 07/31/01 End: - Due: -

Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00070265 Org: User:
Start: 08/31/03 End: - Due: -

Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00045097 Org: User:
Start: 05/31/02 End: 07/31/07 Due: 07/31/08

Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00001437 Org: User:
Start: 06/30/95 End: 03/31/00 Due: 03/31/01

Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01239368 Org: User:
Start: 11/10/10 End: 08/16/17 Due: 08/16/18

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Phase: N/A Priority: Normal
NCT ID: NCT03055013 Org: User:
Start: 04/28/17 End: 06/09/31 Due: 06/09/32

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02780804 Org: User:
Start: 01/06/17 End: 09/30/21 Due: 09/30/22

Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00052728 Org: User:
Start: 12/31/02 End: 07/31/06 Due: 07/31/07

Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01468896 Org: User:
Start: 10/26/11 End: 03/19/26 Due: 03/19/27

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00017264 Org: User:
Start: 06/30/02 End: - Due: -

A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00001442 Org: User:
Start: 07/31/95 End: 06/30/04 Due: 06/30/05

Eflornithine in Treating Patients With Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003814 Org: User:
Start: 02/28/99 End: 05/31/07 Due: 05/31/08

Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing

Phase: N/A Priority: Normal
NCT ID: NCT00341185 Org: User:
Start: 03/05/98 End: 11/18/16 Due: 11/18/17

Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions

Phase: N/A Priority: Normal
NCT ID: NCT00026793 Org: User:
Start: 04/23/01 End: 12/20/17 Due: 12/20/18

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01093222 Org: User:
Start: 04/30/10 End: 09/30/14 Due: 09/30/15

Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples

Phase: N/A Priority: Normal
NCT ID: NCT00001814 Org: User:
Start: 04/30/99 End: 01/31/01 Due: 01/31/02

Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03269669 Org: User:
Start: 01/23/18 End: 12/31/25 Due: 12/31/26

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01425879 Org: User:
Start: 04/30/11 End: 05/31/14 Due: 05/31/15

Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00369551 Org: User:
Start: 06/30/06 End: - Due: -

A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00001498 Org: User:
Start: 02/29/96 End: 12/31/00 Due: 12/31/01

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00005064 Org: User:
Start: 02/29/00 End: - Due: -